PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations

NCT ID: NCT06025253

Last Updated: 2024-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

728 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2026-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many factors influence the risk of wound complications. Notably, the presence of unreconstructed proximal occlusive arterial disease is a major influence on stump healing. Patient factors such as smoking, diabetes, obesity, malnutrition and chronic kidney disease are non-modifiable, particularly in the short-term setting. However, surgical factors may be altered in an effort to reduce the risk of wound complications.

One option amenable to alteration is what dressing is applied to the closed incision upon procedure completion. The type of dressing may influence factors such as bacterial access to the wound, the development of collections of blood or fluid in the wound or fluid oozing from the wound. Collectively, these wound factors increase the risk of wound infection. Therefore, dressings which reduce these factors have the potential to reduce wound breakdown, thereby reducing the burden for patients and healthcare systems.

The investigators propose to conduct a multicentre randomised controlled trial comparing prophylactic single-use negative pressure wound therapy with standard dressings in patients with a closed incision following major lower extremity amputation in terms of SSI incidence, wound healing complications and scar appearance, patient quality of life and financial impact on the patient and healthcare system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Surgical Wound Infection Cosmesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Negative Pressure Wound Therapy.

Application of a negative wound pressure therapy dressing to the wound post major lower extremity amputation

Group Type EXPERIMENTAL

Negative Pressure Wound Therapy

Intervention Type DEVICE

Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation

Standard Wound dressing

Application of sterile standard gauze dressing to the wound post major lower extremity amputation

Group Type ACTIVE_COMPARATOR

Standard Wound Dressing

Intervention Type DEVICE

Application of standard wound dressing post major lower extremity amputation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Negative Pressure Wound Therapy

Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation

Intervention Type DEVICE

Standard Wound Dressing

Application of standard wound dressing post major lower extremity amputation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older;
* Patients undergoing major lower extremity amputation, including below-knee amputation, through-knee amputation and above-knee amputation, for any indication;
* Patients with primary closure of the surgical incision using either interrupted or continuous sutures

Exclusion Criteria

* Patients \<18 years;
* Women who are pregnant and/or breast-feeding;
* Patients with amputations performed without primary skin closure, including guillotine amputations, amputations deliberately left open for drainage purposes and amputations with soft tissues defects at the stump;
* Patients with amputations where skin glue is the only means of skin closure
* Patients with a clinically absent femoral pulse
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Royal College of Surgeons, Ireland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stewart Walsh, Prof

Role: PRINCIPAL_INVESTIGATOR

University Hospital Galway (UHG)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beaumont Hospital, Beaumont rd,Dublin 9, D09V2N0

Dublin, , Ireland

Site Status NOT_YET_RECRUITING

St Jamess Hospital

Dublin, , Ireland

Site Status NOT_YET_RECRUITING

St Vincents University Hospital

Dublin, , Ireland

Site Status NOT_YET_RECRUITING

Tallaght University Hospital

Dublin, , Ireland

Site Status NOT_YET_RECRUITING

University Hospital Galway

Galway, , Ireland

Site Status RECRUITING

University Hospital Limerick

Limerick, , Ireland

Site Status NOT_YET_RECRUITING

University Hospital Waterford

Waterford, , Ireland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stewart Walsh

Role: CONTACT

353 915 2422

Megan Foley

Role: CONTACT

353 915 2422

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daragh Moneley

Role: primary

(01) 8093131

Zenia Martin

Role: primary

Hillary Hurley

Role: primary

Emily Boyle

Role: primary

Stewart Walsh

Role: primary

Zeeshan Ahmed

Role: primary

Gergely Gosi

Role: primary

051-848303

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCSI- PINTA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.